Komori
FunPep (4881) · InitiativeFirst stated

Joint research into a therapeutic vaccine combining antibody-inducing peptide and mRNA technologies

First written in 2026-06-01. . Latest entry: 2026-06-01.

1entries
1years
1from disclosures
Share on X
How it moved
Same theme, other companies

This thread is not in a theme yet. When the same subject shows up in other companies' filings, you can compare them here.

Full recordFilings, disclosures and news, newest first
  1. 2026-06-01First statedBusiness alliance

    「This research aims to create a new therapeutic mRNA vaccine by combining our antibody-inducing peptide technology with Crafton Biotechnology's proprietary mRNA technology, including PureCap®.」

    A joint research agreement was concluded with Crafton Biotechnology, and research began into a therapeutic mRNA vaccine combining the company's mRNA technology with antibody-inducing peptide technology.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for FunPep yet. It last moved in the Business alliance of 2026-06-01: "First stated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Joint research into a therapeutic vaccine combining antibody-inducing peptide and mRNA technologies | FunPep Company Limited (4881) | Komori